Viewing nowEnpamide Sustained-Release Tablet (Rebamipide)
Rebamipide 150mg
Tablet · Prescription medication
NovaM Healthcare Co., Ltd.

MFDS item code 202502261 · Approved 2025.08.28
Treatment of acute and chronic gastritis through improvement of gastric mucosal lesions (erosion, bleeding, etc.)
This medication is used to improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling that occur during the acute exacerbation of acute and chronic gastritis.
Adults should take 1 tablet twice a day, once in the morning and once in the evening. This medication should be swallowed whole and should not be divided or chewed.
This drug should not be used in patients who have had an allergic reaction to its components. While taking this medication, gastrointestinal symptoms, infections, and muscle pain may occur, so caution is advised. Most side effects are mild, and serious adverse reactions have been reported infrequently. If severe allergic reactions or shock symptoms occur, stop taking the medication immediately and consult a healthcare professional. Women who are pregnant or can become pregnant should only use this medication if the benefits of treatment are deemed greater than the risks. Additionally, since this medication may be excreted in breast milk, breastfeeding women are advised to avoid nursing while taking it. In children and adolescents, the safety of this medication has not been sufficiently confirmed, and it should be used with caution. The elderly may generally have decreased bodily functions, so special attention should be given to side effects such as gastrointestinal symptoms. This medication should be stored in a safe place out of reach of children and it is recommended not to transfer it to another container.
Gastrointestinal disturbances (nausea, abdominal distension, upper abdominal pain, constipation, diarrhea, dyspepsia, dry mouth, vomiting, heartburn, abdominal pain, belching, taste disturbances), infections and infestations (nasopharyngitis, epididymitis, pharyngotonsillitis), musculoskeletal and connective tissue disorders (muscle pain, joint pain), neurological disorders (dizziness, headache, drowsiness), skin and subcutaneous tissue disorders (dry skin, eczema, pruritus, rash, itchiness, drug rash), psychiatric disorders (depression
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, and it should be kept at room temperature between 1°C and 30°C. Therefore, when using the medication, always keep the container closed and avoid excessively hot or cold places.
White round sustained-release tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 150mg
Tablet · Prescription medication
NovaM Healthcare Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.